30-Mar-2005 - Labcyte Inc.

Labcyte Receives Patent for Producing Mono-Dispersed and Multi-Layer Particles with Focused Acoustics

Labcyte Inc. received its 18th patent. U.S. Patent 6,869,551 discloses the use of focused acoustic energy to create particles with a very narrow distribution of size. Acoustic droplet ejection (ADE) of a solution containing dissolved materials produces these mono-dispersed particles. In addition, multi-layer particles form when droplets are ejected from layered immiscible fluids. ADE droplets solidify via solvent evaporation, exposure to an anti-solvent or via chemical processes such as polymerization. In contrast to other techniques, this method is compatible with volatile and near saturation solutions. It also eliminates the need for a nozzle and thus does not suffer from the clogging that makes other approaches unreliable.

Dr. Elaine J. Heron, Chief Executive Officer of Labcyte Inc., said, "Small particles of controllable size and composition provide predictability in a variety of applications. Uniformity in particle size allows materials to behave and function consistently, an attribute that is especially advantageous for the pharmaceutical industry, where the particle size of a therapeutic agent can affect the dissolution rate, bioavailability, and delivery to targeted portions of the lung."

Facts, background information, dossiers
  • acoustic droplet ejection
More about Labcyte
  • News

    Beckman Coulter strenghtens laboratory automation business

    Beckman Coulter Life Sciences announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with une ... more

    Labcyte and Deerac Fluidics Combine Forces to Enhance Low Volume Liquid Handling

    Labcyte Inc. and Allegro Technologies Limited, which conducts business as Deerac Fluidics, announced that they have reached agreement on the terms for combination of the two companies. Completion of the transaction requires shareholder approval and is expected within one month. Although pr ... more

    Labcyte Receives 22nd Patent for Restoration of Fluid Volume and Composition Using Acoustics

    Labcyte Inc. has received its 22nd patent (U.S. Patent 6,932,097), which discloses how to use acoustics to monitor the composition and volume of a fluid and maintain those parameters via active fluid supplementation. In many applications, both chemical and biological, fluid composition can ... more

  • Companies

    Labcyte Inc.

    Labcyte Inc., headquartered in Sunnyvale, California, is the world leader in providing acoustic droplet ejection technology for pharmaceutical and life science applications. The Labcyte acoustic droplet ejection technology has broad applications including compound management, assays, arrayi ... more